NATHAN WILLIAMSON: Open Payments
NPI 1306393061 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,292 in 205 payments from 21 companies in 2025. Trend: 2023 $3,129 · 2024 $3,139 · 2025 $3,292
Food & beverage: $3,292
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $612 |
| AstraZeneca Pharmaceuticals LP | 21 | $586 |
| PFIZER INC. | 42 | $473 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $320 |
| Novo Nordisk Inc | 15 | $249 |
| Amgen Inc. | 12 | $168 |
| Otsuka America Pharmaceutical, Inc. | 8 | $157 |
| Lilly USA, LLC | 13 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $145 |
| Procept Biorobotics Corporation | 2 | $80 |
Products named: NURTEC ODT, AIRSUPRA, Kerendia, VRAYLAR, BREZTRI, REXULTI, UBRELVY, QULIPTA.
Industry payments across AR — which companies pay providers there.
